Sites in Los Angeles and near San Francisco California are enrolling people with severe SCD for a trial to test a gene ...

Columnist Sylvia Amuta works to manage her anxiety after noticing that her own stress has a negative impact on her cousin ...

Cyclosporin H boosts a new lentivirus-delivered gene therapy with enhanced anti-sickling properties in blood stem cells from ...

Columnist Oluwatosin Adesoye addresses some of the myths about blood transfusion and explains why it's important in managing ...

Digital cognitive behavioral therapy was as effective as pain education at easing sickle cell pain, a study reported.

Too many people with sickle cell disease are dying preventable deaths. This negligence must end, columnist Mary Shaniqua says ...

The Clinton Health Access Initiative (CHAI) is leading a project that aims to expand access to diagnostic tests and treatments for sickle cell disease (SCD). The project is being funded by a ...

I recently wrote about my disappointment regarding Pfizer’s decision to withdraw Oxbryta (voxelotor) from global markets as a treatment option for sickle cell disease. Therefore, it seems only fitting ...